Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy

Intensive Care Medicine

Volumn 38, Issue 1, 2012, Pages 20-28

  Zhang, Zhongheng ^a   Hongying, Ni ^a  

^a Jinhua Central Hospital   (China)

Author keywords

Circuit life span; Continuous renal replacement therapy; Regional citrate anticoagulation; Systematic review

Indexed keywords

CITRIC ACID; ANTICOAGULANT AGENT;

ACID BASE BALANCE; ALKALOSIS; ANTICOAGULATION; BLEEDING; BLEEDING TENDENCY; CLINICAL EFFECTIVENESS; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; ELECTROLYTE BALANCE; HEMODIALYSIS PATIENT; HUMAN; HYPERNATREMIA; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; VASCULAR PATENCY; BLOOD CLOTTING; CRITICAL ILLNESS; FEMALE; INTENSIVE CARE UNIT; MALE; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ANTICOAGULANTS; BLOOD COAGULATION; CITRATES; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

EID: 84859337936     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-011-2438-3     Document Type: Review

References (26)

1. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R (2003) Continuous is not continuous: the incidence and impact of circuit ''downtime'' on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 29:575-578
2. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA (2007) Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 33:1563-1570
3. Tsang DJ, Tuckfield A, Macisaac CM (2011) Audit of safety and quality of the use of enoxaparin for anticoagulation in continuous renal replacement therapy. Crit Care Resusc 13:24-27
4. Gajra A, Vajpayee N, Smith A, Poiesz BJ, Narsipur S (2007) Lepirudin for anticoagulation in patients with heparininduced thrombocytopenia treated with continuous renal replacement therapy. Am J Hematol 82:391-393
5. Link A, Girndt M, Selejan S, Mathes A, Bohm M, Rensing H (2009) Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med 37:105-110
6. Windeløv NA, Ostrowski SR, Perner A, Johansson PI (2010) Transfusion requirements and clinical outcome in intensive care patients receiving continuous renal replacement therapy: comparison of prostacyclin vs. heparin prefilter administration. Blood Coagul Fibrinolysis 21:414-419
7. Pinnick RV, Wiegmann TB, Diederich DA (1983) Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 308:258-261
8. Aman J, Nurmohamed SA, Vervloet MG, Groeneveld AB (2010) Metabolic effects of citrate-vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study. J Crit Care 25:120-127
9. Tillman J (2009) Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy. Nurs Crit Care 14:191-199
10. Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13
11. Nurmohamed SA, Vervloet MG, Girbes AR, Ter Wee PM, Groeneveld AB (2007) Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study. Blood Purif 25:316-323
12. Fabbri LP, Nucera M, Al Malyan M, Becchi C (2010) Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study. Acta Anaesthesiol Scand 54:92-97
13. Park JS, Kim GH, Kang CM, Lee CH (2011) Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration. Korean J Intern Med 26:68-75
14. Betjes MG, van Oosterom D, van Agteren M, van de Wetering J (2007) Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J Nephrol 20:602-608
15. Fealy N, Baldwin I, Johnstone M, Egi M, Bellomo R (2007) A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration. Int J Artif Organs 30:301-307
16. Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC (2011) Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 26:232-239
17. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J (2005) Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 67:2361-2367
18. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P (2004) Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30:260-265
19. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF (2009) Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37:545-552
20. Jackson SP, Nesbitt WS, Kulkarni S (2003) Signaling events underlying thrombus formation. J Thromb Haemost 1:1602-1612
21. Burry LD, Tung DD, Hallett D, Bailie T, Carvalhana V, Lee D, Ramganesh S, Richardson R, Mehta S, Lapinsky SE (2009) Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy. Ann Pharmacother 43:1419-1425
22. Bos JC, Grooteman MP, van Houte AJ, Schoorl M, van Limbeek J, Nubé MJ (1997) Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis. Nephrol Dial Transplant 12:1387-1393
23. Bohler J, Schollmeyer P, Dressel B, Dobos G, Horl WH (1996) Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 7:234-241
24. Gritters M, Grooteman MP, Schoorl M, Schoorl M, Bartels PC, Scheffer PG, Teerlink T, Schalkwijk CG, Spreeuwenberg M, Nubé MJ (2006) Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 21:153-159
25. Faybik P, Hetz H, Mitterer G, Krenn CG, Schiefer J, Funk GC, Bacher A (2011) Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med 39:273-279
26. Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM (2011) Regional citrate anticoagulation in critically ill patients with liver and kidney failure. J Nephrol. doi:10.5301/JN.2011.8363